Transcription-dependent epidermal growth factor receptor activation by hepatocyte growth factor. - Wikidata - wikimedia - TriplyDB

Transcription-dependent epidermal growth factor receptor activation by hepatocyte growth factor.

Transcription-dependent epidermal growth factor receptor activation by hepatocyte growth factor.

http://www.wikidata.org/entity/Q30436756

about

Cyr61 mediates hepatocyte growth factor-dependent tumor cell growth, migration, and Akt activation Molecular characterizations of glioblastoma, targeted therapy, and clinical results to date Alternative signaling pathways as potential therapeutic targets for overcoming EGFR and c-Met inhibitor resistance in non-small cell lung cancer Hepatocyte growth factor sensitizes brain tumors to c-MET kinase inhibition.EGFR-targeted therapy in malignant glioma: novel aspects and mechanisms of drug resistance.EphB2 receptor controls proliferation/migration dichotomy of glioblastoma by interacting with focal adhesion kinase Lipid metabolism enzyme ACSVL3 supports glioblastoma stem cell maintenance and tumorigenicity EGFRvIII and c-Met pathway inhibitors synergize against PTEN-null/EGFRvIII+ glioblastoma xenografts.Receptor tyrosine kinase coactivation networks in cancer A Phosphotyrosine Proteomic Screen Identifies Multiple Tyrosine Kinase Signaling Pathways Aberrantly Activated in Malignant Mesothelioma.DNER, an epigenetically modulated gene, regulates glioblastoma-derived neurosphere cell differentiation and tumor propagation.Co-activation of epidermal growth factor receptor and c-MET defines a distinct subset of lung adenocarcinomas.Glial progenitors as targets for transformation in glioma.Profiling the dynamics of a human phosphorylome reveals new components in HGF/c-Met signaling.Activation of EGFR by proteasome inhibition requires HB-EGF in pancreatic cancer cells Prognostic significance of overexpression of c-Met oncoprotein in cholangiocarcinoma PTEN reconstitution alters glioma responses to c-Met pathway inhibition.Hepatocyte growth factor (HGF) autocrine activation predicts sensitivity to MET inhibition in glioblastoma.Biomarker analyses from a placebo-controlled phase II study evaluating erlotinib±onartuzumab in advanced non-small cell lung cancer: MET expression levels are predictive of patient benefit.Emerging insights into the molecular and cellular basis of glioblastoma.Ligand-independent activation of MET through IGF-1/IGF-1R signaling.Morphine-induced epidermal growth factor pathway activation in non-small cell lung cancer.Decorin is a novel antagonistic ligand of the Met receptor.Targeted therapy for malignant glioma patients: lessons learned and the road ahead.Regulation of glioblastoma stem cells by retinoic acid: role for Notch pathway inhibition.Met interacts with EGFR and Ron in canine osteosarcoma Does hepatocyte growth factor/c-Met signal play synergetic role in lung cancer?MET4 expression predicts poor prognosis of gastric cancers with Helicobacter pylori infection Cellular functions regulated by phosphorylation of EGFR on Tyr845.Erk2 but not Erk1 regulates crosstalk between Met and EGFR in squamous cell carcinoma cell lines.CRM197 in Combination With shRNA Interference of VCAM-1 Displays Enhanced Inhibitory Effects on Human Glioblastoma Cells.HGF induces novel EGFR functions involved in resistance formation to tyrosine kinase inhibitors.Regulation of glioblastoma multiforme stem-like cells by inhibitor of DNA binding proteins and oligodendroglial lineage-associated transcription factors.Synergism of EGFR and c-Met pathways, cross-talk and inhibition, in non-small cell lung cancer EGF receptor activates MET through MAPK to enhance non-small cell lung carcinoma invasion and brain metastasis.Methylated cis-regulatory elements mediate KLF4-dependent gene transactivation and cell migration FasL gene knock-down therapy enhances the antiglioma immune response.Mechanisms of receptor tyrosine kinase activation in cancer.c-Met and Other Cell Surface Molecules: Interaction, Activation and Functional Consequences.Krüppel-like factor 4 (KLF4) induces mitochondrial fusion and increases spare respiratory capacity of human glioblastoma cells.

P2860

Q24606703-771F7128-5576-427A-8FE1-8E5438C633C2 Q26822717-F26964A9-92CD-42A4-AD7C-0F3A5AD13097 Q28534819-3A55A421-0676-40EF-955C-9444837FE4F3 Q30414265-32C1726A-EE22-4D7C-891F-24122DC0C0C8 Q30456087-75AF555A-D349-4AEA-93A6-B7BF334728B4 Q30514025-3AF2B41B-2E83-47F1-A672-C8759DBE1B22 Q33747559-2EB0BAF8-D08F-4831-BAF3-CD1371C13410 Q33756853-089269F3-AD5A-4D15-840D-9F2215D172A6 Q33871842-F1360459-C3BA-4151-9185-020E31479150 Q34018570-D6076F9A-122B-4BC4-9B22-31D4A6A7DB8E Q34111103-AF314B8F-E4A6-4BF1-8629-973914869519 Q34254343-9547068D-743B-41E5-8547-80FDA54B7CF9 Q34735661-B6C58F36-B5AC-40F5-B864-7D9FBC42C512 Q34983997-93124596-9324-43A7-BD04-1AB2BA42D97C Q35099053-0BFC79B4-7F71-4693-B524-24955F880078 Q35108386-6709F632-B813-4EFB-B6E5-A9A8D2E0918B Q35188319-EF8A30D9-D126-4A36-B430-D76C4F64A54C Q35673676-DD5500C6-E60A-4221-B707-3A32D8805F64 Q35858331-8377EFB1-1377-4D55-A4A1-0F0E9CFEE0A3 Q35914897-4B9480DD-08B8-48EE-B459-7199556EC62E Q37018397-D07E24F9-F499-416F-97A0-4F1DCA7A2766 Q37051227-7F822EAF-AE40-40E1-8A8C-EEDAC6DDEC75 Q37263981-77F53ECB-2827-4245-910B-3B52D4A1C2B6 Q37533648-E6B9093A-85E0-4836-A9BB-5E926C7FA33F Q37640483-D1696241-D6BD-4DC9-B4C1-0C4D59AAB42B Q37672081-CAE42754-1346-4BAB-93DA-5122127BB370 Q37697193-B99D47F5-95CC-4B46-86CC-5D42611E51A6 Q37735662-F8C37A0D-65E4-4DD5-A792-DC667B2D9417 Q38109021-0E71B814-C687-4217-8953-AF910EA88D93 Q38885876-3976F21C-FE13-4456-860C-D9500E0873A5 Q38958467-38EB8C13-0907-4ADB-A95D-41C51EAF2D31 Q39263953-C58C4B92-A4F4-44E4-8BC3-11D2EF7DD7AC Q39387580-C0D292C7-99ED-46A0-95AE-474034D0CA61 Q41969702-AF0DDFC0-694D-4783-8DDE-98228F219402 Q42108367-0DAA7FA1-F128-420B-8112-418F469A5C3B Q42209913-0CD45CC5-231B-426B-A8C6-4609EA8B29FE Q42425989-7990C482-3A0D-459A-9E85-932D94B0183B Q49888000-A5DB1DF7-8FB0-461C-A6F8-88A5D45EC18D Q50985108-8DD22DCB-A1D4-4FC5-9C7B-156B73547661 Q51736068-38DFFF7E-0B64-4D50-AC01-79F9B6BFBC1C

P2860

Transcription-dependent epidermal growth factor receptor activation by hepatocyte growth factor.

http://www.wikidata.org/entity/Q30436756

description

2008 nî lūn-bûn

@nan

2008 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Transcription-dependent epider ...... n by hepatocyte growth factor.

@ast

Transcription-dependent epider ...... n by hepatocyte growth factor.

@en

type

label

Transcription-dependent epider ...... n by hepatocyte growth factor.

@ast

Transcription-dependent epider ...... n by hepatocyte growth factor.

@en

prefLabel

Transcription-dependent epider ...... n by hepatocyte growth factor.

@ast

Transcription-dependent epider ...... n by hepatocyte growth factor.

@en

P1433

Q30436756-D0C86950-EB32-4E7E-8212-C45308BE24B1

P1476

Q30436756-99BC0B01-C126-4384-A94B-011115F11627

P2093

Q30436756-5C32B792-8589-4DFC-AEFD-66CD62B51274

Q30436756-6CA3C634-0BA1-49E9-88A8-D2BC26AA6509

Q30436756-A677F269-6482-4E6E-87D4-AE2626461279

Q30436756-AE84CBBE-11B8-4129-B66E-DB835BFA7BB0

Q30436756-B03699D6-E17B-42E1-A4CF-18488CD8DAFB

Q30436756-D79DA112-A290-4D70-BB0E-8852D4C8C912

Q30436756-F4CB0251-F02C-4288-9525-5047242918C4

P2860

Q30436756-10120DED-9CED-43AE-93A0-91A7DA5BAE54

Q30436756-1C49AFC3-7787-4E16-A5CB-3F977A1858F9

Q30436756-2DBFC5EF-7466-4A7E-B712-FFE353C82486

Q30436756-352B3196-5EBA-464C-BCCC-7E2F375A879B

Q30436756-36F84988-0934-477B-A7A3-E603560775D2

Q30436756-3A1293D7-AF03-4C40-84D0-D155FE2728AE

Q30436756-3A9C1FC6-81A8-4CD1-BAEE-7397099CBA0D

Q30436756-3B6287AA-4F93-44F6-BBE1-1DFF8C8E2A19

Q30436756-58F80020-F58D-4DED-BB09-70D789E0AB5D

Q30436756-6869F14B-5D7D-4CA3-904C-3808FEE5AEF1

P304

Q30436756-55EBF61C-ED8A-40E2-A01C-36F824B8E933

P31

Q30436756-C0213A34-6BB5-4735-A73A-D65EB2137663

P356

Q30436756-16FAA16F-1A39-4DB6-998A-5901118D7FB1

P433

Q30436756-9243F3A5-F14F-46FB-8293-7E986989C843

P478

Q30436756-00240B3C-443B-48DC-A4B0-E5D9E7D6487B

P577

Q30436756-00076EBF-4FA2-4A23-AA09-791D01586CF9

P5875

Q30436756-5BEC7AAD-6824-4AED-AC8E-F9DF851ADABF

P698

Q30436756-C83353D0-CBD3-4BD7-90FA-7EBC243736DD

P932

Q30436756-617B17D0-D1D9-4930-BC89-A246878D8324

P356

1541-7786.MCR-07-0236

P1433

Molecular Cancer Research

P1476

Transcription-dependent epider ...... n by hepatocyte growth factor.

@en

P2093

Eliot M Rosen

http://www.w3.org/2001/XMLSchema#string

John Laterra

http://www.w3.org/2001/XMLSchema#string

Roger Abounader

http://www.w3.org/2001/XMLSchema#string

Shuli Xia

http://www.w3.org/2001/XMLSchema#string

Thomas E Reznik

http://www.w3.org/2001/XMLSchema#string

Yingying Sang

http://www.w3.org/2001/XMLSchema#string

Yongxian Ma

http://www.w3.org/2001/XMLSchema#string

P2860

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications

Neutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor (HGF/SF) display antitumor activity in animal models

Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis

The natural history of EGFR and EGFRvIII in glioblastoma patients

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling.

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

A selective small molecule inhibitor of c-Met kinase inhibits c-Met-dependent phenotypes in vitro and exhibits cytoreductive antitumor activity in vivo

P304

139-150

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1541-7786.MCR-07-0236

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2008-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5616970

http://www.w3.org/2001/XMLSchema#string

P698

18234969

http://www.w3.org/2001/XMLSchema#string

P932

2839502

http://www.w3.org/2001/XMLSchema#string